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 Letter to the Editor 
aim of this single-blind 2-arm parallel randomized controlled trial 
(trial registration NTR2503; approved by METIGG, an indepen-
dent medical ethics committee) was to examine whether adding 
M-CT to TAU is clinically superior to TAU alone over 24 months 
(primary outcome) in remitted recurrently depressed individuals. 
Details about the study design can be found elsewhere  [7] .
 Individuals were recruited via media, general practitioners, and 
mental health care institutions, and screened for eligibility with a 
telephone version of the Structured Clinical Interview for DSM-IV 
axis I disorders (SCID-I) and the Hamilton Rating Scale for De-
pression (HRSD). Individuals aged between 18 and 65 years were 
included if they had experienced at least 2 (unipolar) depressive 
episodes, had been in remission for at least 8 weeks but no longer 
than 24 months according to the DSM-IV assessed with the SCID-
I, and had a current score of  ≤ 10 on the HRSD. Participants pro-
vided informed consent prior to randomization and were included 
between mid-September 2010 and August 2013. Simple random-
ization was undertaken (1: 1 ratio) by an independent researcher 
using computer-generated random numbers with STATA. M-CT 
consisted of 8 online modules based on PCT, a face-to-face treat-
ment targeting cognitive vulnerability factors. In M-CT, partici-
pants were recommended to work on 1 module per week, taking 
approximately 20 min plus 10-min homework assignments. Mini-
mal therapist support was administered, yielding a minimum of 2 
telephone sessions with a maximum duration of 30 min with a li-
censed clinical psychologist. TAU consisted of no treatment, (af-
ter) care by a general practitioner, or (after) care in a specialized 
mental health care center. 
 To detect an absolute difference of 20% in the cumulative inci-
dence of depressive relapse/recurrence over 24 months, with 80% 
power, a 2-sided 5% alpha level, and assuming relapses/recurrenc-
es in 50% of the participants and a 20% attrition rate, we aimed to 
include 268 participants. The intention-to-treat (ITT) principle 
was used, analyzing all participants regardless of adherence to the 
randomized condition. The primary outcome was time-related 
proportion of relapse/recurrence according to the DSM-IV as-
sessed with the SCID-I by blinded interviewers after 3, 12, and 24 
months. Treatment response conditional on number of previous 
depressive episodes assessed with the SCID-I, chronic somatic ill-
ness assessed with the Nemesis Somatic illnesses list, and type of 
TAU were examined explicitly. Secondary outcomes were number 
of relapses/recurrences based on DSM-IV criteria assessed with 
the SCID-I and the level of depressive symptoms assessed with the 
Inventory of Depressive Symptomatology Self-Report (IDS-SR) at 
10 intervals.
 In total, 288 individuals were eligible, of whom 264 were ran-
domized to M-CT added to TAU ( n =  132) or TAU alone ( n =  132). 
Most participants were highly educated (61%) and female (75%), 
with a mean age of 46 years (±10.8) and median number of previ-
ous depressive episodes of 4. Overall, 29 participants dropped out 
immediately after randomization and 24 were lost to follow-up. 
 As major depressive disorder (MDD) is highly recurrent, inter-
national practice guidelines recommend maintenance antidepres-
sant medication and/or psychological treatment after acute MDD 
to prevent relapse/recurrence  [1] . Preventive cognitive therapy 
(PCT) is specifically developed for relapse prevention in depres-
sion and is effective in reducing relapse/recurrence over 2–10 years 
 [2, 3] . Since resources in clinical practice are scarce, internet-based 
relapse prevention programs might be a promising alternative. 
Small to moderate effects of internet-based interventions were 
found without therapist support and higher effects with therapist 
support  [4] . The short-term (secondary) results of the current ran-
domized controlled trial showed a more favorable course of de-
pressive symptoms over 3 months in participants receiving an in-
ternet-based version of PCT (mobile cognitive therapy, M-CT) 
added to treatment as usual (TAU) compared to TAU alone  [5] . 
Thus far, little is known about the long-term effectiveness of inter-
net-based relapse prevention programs. Only one study in par-
tially remitted participants has examined the effect of a 10-week 
guided internet-based relapse prevention program for recurrent 
depression over 24 months, showing promising results  [6] . The 
 Received: August 21, 2017 
 Accepted after revision: November 4, 2017 
 Published online: January 6, 2018 
 © 2018 S. Karger AG, Basel 
 www.karger.com/pps 
 Psychother Psychosom 2018;87:55–57 
 DOI: 10.1159/000485039 
 No Sustainable Effects of an Internet-Based 
Relapse Prevention Program over 24 Months in 
Recurrent Depression: Primary Outcomes of a 
Randomized Controlled Trial 
 Nicola S. Klein a , Gemma D. Kok b , Huibert Burger c, d , 
Evelien van Valen e , Heleen Riper f–h , Pim Cuijpers f, g , Jack Dekker f, i , 
Filip Smit f, g, j , Colin van der Heiden k, l , Claudi L.H. Bockting a, m 
 a  Department of Clinical Psychology, University of Groningen, 
Groningen,  b  Department Tripolis, GGZ Drenthe,  Assen , 
 c  Department of General Practice, University of Groningen, 
University Medical Center Groningen,  Groningen ,  d  Radboud 
University Medical Center, Radboud Institute for Health 
Sciences,  Nijmegen ,  e  Department of Geriatrics, University 
Medical Center Utrecht, Utrecht,  f  Department of Clinical, Neuro 
and Developmental Psychology, Vrije Universiteit, Amsterdam, 
 g  Amsterdam Public Health, VU University Medical Center, 
Amsterdam,  h  GGZ inGeest, Amsterdam,  i  Research Department 
Arkin Mental Health Institute, Amsterdam,  j  Department of 
Public Mental Health, Trimbos Institute (Netherlands Institute 
of Mental Health and Addiction),  Utrecht ,  k  Department of 
Psychology, Education and Child Studies, Erasmus University 
Rotterdam, Rotterdam,  l  PsyQ Mental Health Care Center, 
 Rotterdam , and  m  Department of Psychiatry, Academic Medical 
Center, University of Amsterdam,  Amsterdam , The Netherlands
 
 Claudi L.H. Bockting 
 Department of Psychiatry, Academic Medical Center 
 University of Amsterdam, Meibergdreef 9 
 NL–1105 AZ Amsterdam (The Netherlands) 






Baseline characteristics in the ITT sample and of participants with 
follow-up data were comparable and balanced over treatment con-
ditions, except for a slight imbalance in gender and severity of the 
last depressive episode. Mean total therapist support in M-CT was 
17.3 min per participant (range: 0–70), and 68% ( n =  90) finished 
at least 5 modules.
 After 24 months, the cumulative relapse/recurrence rate ac-
cording to Kaplan-Meier estimates was 0.44 in M-CT and 0.49 in 
TAU.  Figure 1 shows that over time, the proportion free of relapse/
recurrence was higher in M-CT compared to TAU, but this effect 
was not statistically significant (log-rank X 2 [1] = 1.73,  p = 0.189). 
The Cox regression showed no statistically significant difference 
between conditions (hazard ratio, HR = 0.77, 95% CI = 0.53–1.14, 
 p = 0.190). Treatment condition did not interact with number of 
previous depressive episodes (HR = 0.74, 95% CI = 0.34–1.61,  p = 
 0.447), chronic somatic illness (HR = 0.60, 95% CI = 0.26–1.35, 
p =  0.216), and type of TAU (HR = 0.87, 95% CI = 0.57–1.35,  p = 
 0.543). Sensitivity analyses controlling for imbalanced baseline 
variables, including only participants that completed at least 5 
modules, and using multiple imputation to address missing data, 
yielded comparable results. No statistically significant results were 
found on secondary outcomes (Poisson regression on number of 
relapses: incidence rate ratio = 0.87, 95% CI = 0.64–1.19, p =  0.393; 
linear mixed models on depressive symptoms: B = 0.31, 95% CI = 
–0.09–0.70,  p =  0.131). Additional information about the methods 
and results can be found at https://www.claudibockting.com/
research/supplementary-material.
 We did not find statistically significant effects on our primary 
and secondary outcomes over 24 months, which indicates that 
M-CT has no long-term protective effect. This finding is in line 
with a recent meta-analysis demonstrating that guided and un-
guided internet-based treatments were effective in the short term 
but not beyond 6 months posttreatment  [8] . However, our sober-
ing long-term findings contrast with our initial finding where 
M-CT resulted in a favorable course of depressive symptoms over 
3 months  [5] and with the promising findings of Holländare et al. 
 [6] in partially remitted individuals using an internet-based re-
lapse prevention program. Long-term effects of face-to-face PCT 
and other face-to-face relapse prevention strategies such as mind-
fulness-based cognitive therapy and well-being therapy have been 
demonstrated  [9] . As internet-based interventions have better ef-
fects with therapy support  [4] , we hypothesize that actively pre-
scribing more support might have maintained our short-term re-
sults. In the guided internet-based relapse prevention program of 
Holländare et al.  [6] , the mean therapist time was 150 min where-
as in our study this was 17.3 min. Moreover, in a randomized con-
trolled trial examining a similar population, PCT administered as 
bibliotherapy with 110.2 min of therapy support did significantly 
reduce the risk of relapse/recurrence after 12 months  [10] . Future 
studies should examine whether increased therapist support is as-
sociated with better effects in relapse prevention studies.
 Since most participants in M-CT used minimal therapist sup-
port, we were not able to examine whether high therapist support 
is associated with better outcomes. Several other limitations need 
to be acknowledged, including the generalizability (relatively high 
number of highly educated females) and the fact that we could not 
examine the effects of mood monitoring in M-CT on depressive 
relapse/recurrence. 
 In contrast to our expectations, a psychological internet-based 
relapse prevention program added to TAU did not result in a sub-
stantially better protection against relapse/recurrence compared to 
TAU alone. Future studies should examine the long-term effec-
tiveness of internet-based interventions and the optimal dosage of 
therapist support.
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 Fig. 1. Survival curves over 24 months in mobile cognitive therapy 
(M-CT) added to treatment as usual (TAU) (n = 132) and TAU 
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